A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies
- Conditions
- Lung Cancer
- Interventions
- Procedure: Surgeries
- Registration Number
- NCT03421093
- Lead Sponsor
- West China Hospital
- Brief Summary
The study was designed to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors
- Detailed Description
The trial is a multi-centre real-world non-interventional observational study to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors via a retrospectively review method on the study data on patient demographic/tumor biological characteristics and clinical treatments.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21777
- Age >= 18 years old;
- Pathologically diagnosed lung malignant tumors after surgeries;
- Patients with lung surgeries;
- Patients with complete medical health records and follow-up visit information (at least one follow-up visit);
- Patients who were not performed with surgeries;
- Pathologically diagnosed patients with benign diseases after surgeries;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Surgeries and adjuvant therapies Surgeries Surgeries or surgeries plus adjuvant therapies
- Primary Outcome Measures
Name Time Method Demographic characteristics of the patients with lung malignant tumors who received surgeries 2014 - 2017 Demographic characteristics of the patients with lung malignant tumors who received surgeries of thoracotomy, video-assistant thoracic surgery or robotic thoracic surgery as measured by:
* Age
* Gender
* Payment types
* Insurance types
* Smoking history
* Complications and symptoms of complications
* Respiratory functions
* Type of diagnoses
- Secondary Outcome Measures
Name Time Method Location of tumors and tumor sizes 2014 - 2017 Location of tumors and tumor sizes
Type of biomarkers 2014 - 2017 Type of biomarkers
Tumor clinical/pathological staging 2014 - 2017 Tumor clinical/pathological staging
Trial Locations
- Locations (10)
China-Japan Friendship Hospital
🇨🇳Beijing, Beijing, China
China PLA General Hospital
🇨🇳Beijing, Beijing, China
Tianjin Chest Hospital
🇨🇳Tianjin, Tianjin, China
Henan cancer hospital
🇨🇳Zhengzhou, Henan, China
Tongji Hospital Affiliated to Huaxi Technology University
🇨🇳Wuhan, Hubei, China
Jiangsu cancer hospital
🇨🇳Nanjing, Jiangsu, China
Xi'an Tangdu Hospital
🇨🇳Xi'an, Shaanxi, China
Shanghai Chest Hospital
🇨🇳Shanghai, Shanghai, China
West China Hospital, Sichuan University
🇨🇳Chengdu, Sichuan, China
First Hospital Affiliated to Zhejiang University
🇨🇳Hangzhou, Zhejiang, China